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ABSTRACT
Purpose: In this study, we propose a novel laparoscopy-based renal denervation (RDN) system for
treating patients with resistant hypertension. In this feasibility study, we investigated whether our pro-
posed surgical instrument can ablate renal nerves from outside of the renal artery safely and effectively
and can overcome the depth-related limitations of the previous catheter-based system with less dam-
age to the arterial walls.
Method: We designed a looped bipolar electrosurgical instrument to be used with laparoscopy-based
RDN system. The tip of instrument wraps around the renal artery and delivers the radio-frequency (RF)
energy. We evaluated the thermal distribution via simulation study on a numerical model designed
using histological data and validated the results by the in vitro study. Finally, to show the effectiveness
of this system, we compared the performance of our system with that of catheter-based RDN system
through simulations.
Results: Simulation results were within the 95% confidence intervals of the in vitro experimental
results. The validated results demonstrated that the proposed laparoscopy-based RDN system produces
an effective thermal distribution for the removal of renal sympathetic nerves without damaging the
arterial wall and addresses the depth limitation of catheter-based RDN system.
Conclusions: We developed a novel laparoscope-based electrosurgical RDN method for hypertension
treatment. The feasibility of our system was confirmed through a simulation study as well as in vitro
experiments. Our proposed method could be an effective treatment for resistant hypertension as well
as central nervous system diseases.
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Introduction
Hypertension is a growing global public health problem due to
multiple reasons, including an aging population and the rising
rates of obesity [1,2]. Approximately 10% of patients diagnosed
with hypertension have resistant hypertension, which is
defined as blood pressure that remains above the desired level
despite treatment with three antihypertensive agents of differ-
ent classes [1] and blood pressure that is controlled using
more than four medications [2]. Resistant hypertension is a ser-
ious condition leading to various life-threatening clinical com-
plications, such as heart failure, stroke, renal failure and heart
disease [1,3]. Thus, treating resistant hypertension clinically is
very important for the patient’s longevity and quality of life.
Sympathetic nerves play an important role in long-term
blood pressure regulation in humans [4,5]. The increased
sympathetic activity has been implicated as the primary pre-
cursor of hypertension in both humans and in animal models
[6]. Furthermore, there is growing evidence that abnormal
renal function in hypertension is due to the increased activity
of renal sympathetic nerves [7]. Thus, an open surgical pro-
cedure to remove renal sympathetic nerves for treating
hypertension called Sympathectomy was employed in 1930
[8–10]. Although this technique provided effective treatment,
its use was discontinued because of its highly invasive nature
and associated complications, such as perioperative morbid-
ity, mortality and long-term complications [11,12].
Recently, a minimally invasive procedure called renal
denervation (RDN) system has been developed as an effect-
ive method to remove renal nerves for treating resistant
hypertension. The RDN procedure selectively removes the
hyperactive renal sympathetic nerves using a radiofrequency
(RF) ablation technique, thus controlling hypertension. A
catheter-based RDN system, a prominent representative sys-
tem for the RDN procedure, has demonstrated promising
results with minimal side effects in nonrandomized studies
and unblended randomised trials [13–15]. However, a recent
phase-III randomized controlled trial, investigating the effi-
cacy and safety of this procedure, have found that the cath-
eter-based RDN is not effective and shows no improvement
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in outcomes of patients with resistant hypertension when
compared with the outcomes of the sham procedure [16].
The primary limitation of the catheter-based RDN system,
found through histopathological evaluation of the renal
artery, is that the electrodes placed inside the lumen of the
artery cannot deliver RF energy effectively to all the renal
nerve bundles along the renal artery, especially to the nerves
present beyond 2mm from the lumen surface [17]. Since
sympathetic nerves are located at a distance of 0.5–10mm
from the intima layer of the artery with approximately 31%
of the nerves located between 2 and 10mm from the lume-
n–intima interface [18,19], the catheter-based system could
not deliver sufficient energy to treat the hyperactive nerves.
Higher RF energy could be used to destroy these distant
nerves but may severely damage the intima layer resulting in
serious side effects, such as stenosis. The secondary limitation
of the catheter-based approach is that it could not directly
monitor the temperature rise near the renal nerves outside
the artery during or after the treatment.
In the absence of effective surgical treatment for resistant
hypertension, a laparoscopic approach has been proposed as
an alternative method to overcome the limitations of the
catheter approach [20]. According to Gerber et al. [20], the
laparoscopic approach is capable of removing nerves that are
typically not removed by RF-based catheter ablation. The
claim by Gerber et al. is promising, there have been no stud-
ies published to describe the surgical strategy or instrument
design for the effective laparoscopy-based RDN system. In
this study, for the first time, we propose a laparoscopy-based
RDN system design that ablates the renal nerves from the
exterior of the renal artery by wrapping it around. We dem-
onstrate its feasibility of this system using the numerical
model developed based on clinical data and validated
through extensive in vitro experiments. This system demon-
strates the feasibility of the effective denervation of the renal
nerve present between 0.5 and 10mm from the arterial
lumen. We confirmed the superiority of our system over the
catheter-based RDN system via simulations based on per-
formance. Our results demonstrate that a practical laparo-
scopic system could be developed for the surgical treatment
of resistant hypertension.
Methods
Proposed surgical system of laparoscopy-based RDN
Our surgical RF ablation plan is shown in Figure 1. The tis-
sues surrounding the renal artery is excised from the dorsal
side through trocars to expose the renal artery to allow easy
access for the surgical instruments to perform RF ablation.
The retroperitoneal approach using three trocars is minimally
invasive and reduces the likelihood of complications because
there is no peritoneal violation is involved.
Our surgical tip design objectives were threefold: (1) to com-
pletely remove renal sympathetic nerves without damaging the
renal artery, (2) to minimize the damage to the surrounding tis-
sues by focusing RF heating within the contour of the wrapped
electrode, and (3) to be flexible enough to adapt to different
renal artery sizes. Figure 2 shows the conceptual design of the
proposed surgical instrument with a looped electrode that
meets the desired design objectives. To localize the heating
proximal to the electrodes, the tip structure was configured to
be bipolar, wherein both electrodes were placed side by side.
The RF current, which flows between the electrodes, rapidly
attenuates as the distance of the tissue from the electrodes
increases. To completely remove renal nerves distributed
around the artery, the electrode, which is the end part of the
surgical instrument, was designed to wrap around the renal
artery such that RF energy is delivered to completely remove
sympathetic nerves distributed around the artery. As shown in
Figure 1. Schematic drawing of proposed laparoscopy-based RDN surgical approach.
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Figure 2, a strip of highly conductive elastic material was placed
under the electrodes. Due to its elasticity, the tip remains flat
within the case of the surgical instrument while entering the
body and starts to wrap around the artery when the tip is
pushed out of the case at the surgical site. This elastic strip also
allows the tip to fit to different sizes of the renal artery. In add-
ition, the strip is made of highly conductive material to reduce
the RF field radiating to the posterior part of the electrode due
to the electromagnetic shielding effect of electrically high con-
ductive materials [21]. Therefore, with the metal strip, RF energy
in the rear side of the electrode is minimized preventing any
damage to the normal tissues at the site.
Computational modelling
Tissue modelling
In our previous study, we analyzed the anatomical distribution
of sympathetic nerve fibers around the renal artery using the
nephrectomy tissues from humans. We showed that approxi-
mately 31% of the renal sympathetic nerves are located beyond
2mm from the arterial lumen [19]. To reflect our previous find-
ings in tissue modelling, we developed a realistic three-dimen-
sional (3D) numerical model based on the thinnest of the 174
tissue slides obtained at 40lm intervals, from a representative
tissue. Then, we developed a simplified simulation model shown
in Figure 3(b). In this model, the renal artery diameter was
5mm, the lumen diameter was 2mm, and the thickness of the
blood vessel wall was 1.5mm. The four renal sympathetic nerves
were modelled at 2mm, 2.5mm, 3mm, and 3.5mm because
90% of the nerve fibers are located within 4mm from the
luminal surface of the renal artery, based on our histological
studies. In addition, to verify the RF field radiating to the outside
of the surgical tip, a renal vein located posterior to the renal
artery was modelled with an outer wall diameter of 10mm,
lumen diameter of 8.6mm, and wall thickness of 0.7mm [22].
The surrounding tissue environment was modelled in two
cases depending on the surgical approach. For the laparoscopy-
based RDN system shown in Figure 4(a), the tissues between
the artery and electrodes were assigned as fat and nerves and
the surrounding environment outside the surgical instrument
was assigned gaseous CO2, which is commonly used in laparo-
scopic surgeries; because the perinephric fat and Gerota’s fascia
enclosing the kidney need to be incised via a laparoscopic sur-
gical approach. For the catheter-based RDN system shown in
Figure 4(b), the surrounding tissue was modelled as fat to rep-
resent the catheter-based procedure. Table 1 lists the properties
of the materials included in the simulation.
RF ablation tip modelling
The proposed RF ablation tip was simulated for RF energy
and resulting heat distribution using the Sim4life
Figure 2. Concept design of the surgical instrument for laparoscopy-based RDN.
Figure 3. (a) A realistic computable 3D model generated by histological ana-
lysis. (b) Simplified 3D phantom [mm]. The model includes the renal nerves and
renal arterial wall.
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computational electromagnetic analysis software. The gap
between the bipolar electrodes was 2mm, the width of the
highly conductive metal strip was 3mm, and the total width
of the tip was 5mm such that the surgical device can be
inserted through the 5mm trocar that is commonly used in a
laparoscopic procedure. While performing simulations, all
conductive materials were assigned as stainless steel and
insulation materials were assigned as polyimide.
To compare the safety and efficacy between the catheter-
and laparoscopy-based systems, a simplified 6 F catheter-
based Symplicity Flex (Medtronic, Santa Rosa, CA, USA) with
an outer diameter of 2mm and an inner diameter of 1.8mm
was modelled [23].
Numerical simulation setup
Computational calculation of the temperature distribution
around the electrodes and tissues during RF injection was
performed using Sim4life V3.4 software (ZMT, Zurich,
Switzerland). Sim4life is a simulation platform that provides
computational human phantoms with multi-physics solvers
and advanced tissue models. The multiphysics solvers include
the full electromagnetic wave, quasi-static electromagnetic
and thermodynamic solvers. This tool is useful for developing
novel devices, optimizing design parameters, increasing the
knowledge regarding energy delivery and determining
induced heating [24].
Computation of electric fields
The frequency of the source RF current was 1MHz, which is
considerably less than the resonant frequency of 100MHz, as
shown in Figure 5. Quasi-static electromagnetic solver was
used to calculate low-frequency electromagnetic problems
[25] with the following equation:
r  ~rØ ¼ 0 (1)
where ~e is the complex electric permittivity and Ø is a scalar
potential. The electromagnetic field was recorded to use as a
heat source for the thermal simulations.
Figure 4. Finite element modelling: (a) laparoscopy-based RDN, (b) catheter-based RDN.
Table 1. Electrical and thermal properties of the materials.
q [kg/m3]a r [S/m]b j [W/m/K]c HR [W/m3/K]d
Blood 1049 0.659 0.517 709,090
Blood vessel wall 1101 0.232 0.462 11160.7
Nerve 1075 0.265 0.490 11642.5
Fat 911 0.057 0.212 2012.8
CO2 1.977 0 0.017 0
Gel
Setting 1 950 0.23 0.605 0
Setting 2 0.65
aq¼material density, br¼ electric conductivity, cj¼ thermal conductivity,
dHR¼ heat-transfer rate.
Figure 5. Input impedance of the prototype electrode as a function
of frequency.
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Temperature distribution computation
The temperature changes in the tissues during RF ablation
were calculated using the following Pennes bioheat
Equation (2), which has been extensively used to solve com-
putational bio-electromagnetic problems since its introduc-
tion [26].
qc
@T
@t
¼ r  krTð Þ þ qQþ qS qbqx T  Tbð Þ (2)
where q is the material density, c is the specific heat cap-
acity, T is the tissue temperature, k is the thermal conductiv-
ity, Q is the metabolic heat generation rate, S is the specific
absorption rate, and x is the perfusion rate. The term
‘qbcbqw’ is sometimes referred as the heat-transfer rate (HR).
The perfusion rate of blood was set at 10,000ml/min/kg [27]
to examine the blood cooling effect according to the blood
perfusion rate.
Experimental validation setup
To validate the numerical simulation technique of the RF
ablation device, in vitro experiments were conducted, and
the results were extensively compared with the results of the
simulations performed under the same conditions. For the in
vitro experiments, we constructed a prototype tip and eval-
uated the heating effects of the tip at nine measurement
points. The experimental system for delivering RF energy to
the device and measuring the temperature profile during RF
injection is shown in Figure 6. The system comprised an RF
generator (Tektronix, AFG3101), RF amplifier (Minicircuit, LZY-
22þ), power sensor (Keysight, U2004A), and directional coup-
ler (Minicircuit, ZABDC50–150HPþ). The system was con-
trolled by the LabVIEW 2013 software. The prototype tip
comprised three layers: a metal strip, insulation and two elec-
trodes placed 2mm apart to support bipolar mode. Stainless
steel 304 (SUS304) was used for the construction of the elec-
trodes and metal strip for RF blocking, and the plate was
insulated using a polyimide film. The tip was
24mm 110mm, and the electrodes were 2mm 100mm
(Figure 7(a)).
The experiment was conducted with 6 L gel mixed with
polyacrylic acid and NaCl in a 160mm 430mm 170mm
acrylic water tank. The gel had two conductivity settings as
shown in Table 1: 0.23 S/m (setting 1) and 0.65 S/m (setting
2). The conductivities of the gels reflected those of the blood
vessel walls and blood, respectively, because they are
affected thermally during RDN. Dielectric properties of gels
were measured by a network analyzer (Keysight, E5061B).
The input power was switched on for 6min [28] and then off
for 1min at 1MHz. The source was connected to the elec-
trode via a coaxial cable.
Temperature distribution near the prototype tip was
measured using a fiber optic thermometry system (Luxtron,
m600), which can minimize the potential electromagnetic
interference (Figure 7(b)). Temperature probes were fixed at
the openings in the temperature probe holder that was fabri-
cated using a 3D printer (3 D Systems, Project MJP 2500).
The spacing between openings was 10mm along the x-axis
and 2.5mm along both y- and z-axes to facilitate the meas-
urement at different locations. The fixture holding tempera-
ture probe kept the temperature sensors in position relative
to the electrodes for simultaneous temperature measure-
ment. The experimental protocol is shown in Figure 8. The
measurements were repeated six times for each gel setting
in the three axial directions, thus resulting in 36 measure-
ments. The electromagnetic simulations were performed with
the same initial parameters as in the experiments. The tem-
perature data of both the simulation and validation experi-
ments were normalised by the difference between the initial
and average temperatures during the last 60 s of the power-
on period.
Results
In this section, we validated the numerical model via in
vitro studies by comparing the simulated heating results of
the simplified surgical device tip with the measured results
Figure 6. Experimental system for simulation validation.
Figure 7. (a) Schematic representation of a prototype tip. (b) Temperature
measurement setup. The tip is fixed by the fixture and is connected to coaxial
cable. The temperature is inserted into through the holder and measures the
temperature on the tip. The temperature is measured at nine points, three
points for each three axes.
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under the same condition in vitro. We then use this vali-
dated model to conduct extensive simulation studies for
our prosed laparoscopy-based RDN tip design with the
simplified anatomical phantom that was constructed based
on histological analysis.
Simulation method validation
The simulated temperature distribution around the prototype
tip is shown in Figure 9. The temporal temperature data in
the simulation results were extracted at the same points
measured in the in vitro experiment. The similarity of thermal
patterns during RF ablation between the extracted tempera-
ture in the simulations and the measured temperature in the
in vitro studies for settings 1 and 2 are shown in Figure 10.
The error bars denote ±2 standard deviations for each 60 s
time interval, indicating a 95% confidence interval for the
repeated experimental temperature measurements. In
Table 2, time constants (s), average standard deviation (SD)
and error values (E), calculated as the maximum differences
between the experimental and simulation results, and max-
imum error (Max E) are presented for both the settings.
The simulation results were within 95% confidence intervals
of the experimental results during the RF injection. The aver-
age standard deviation was 0.0312, and the average error
was 2.7%, indicating that the simulation results reflected the
actual temperatures observed during experiments.
These validation results confirmed the excellent agree-
ment between the simulation and experimental results
except for a few discrepancies. These discrepancies arose
between simulation and in vitro experiments due to the dif-
ferences in placement of the temperature probe between
simulation and in vitro experiments. The simulation results
were based on the temperatures at the center of each open-
ing. However, the temperature probe location could not be
fixed in the in vitro because the diameter of the temperature
probe holder (1.2mm) was larger than that of the tempera-
ture probe diameter (0.6mm). Figure 11 shows the best heat
matching results when the simulation results were obtained
with the probe moving across the probe holder along the y-
axis. With setting 1, the average error decreased from 2.9%
to 1.9%, and with setting 2, the error decreased from 3.7% to
2.8%. These results confirm that the source of discrepancies
between the simulations and the in vitro experiments mainly
arose due to the differences in the placement of the probe
and not due to any other fundamental reasons, thus confirm-
ing the credibility of the simulation results.
Heat effect on biological tissues
In vitro experiment results confirmed the validity of our
numerical simulation technique and we used this numerical
technique to simulate the proposed device design in a sim-
plified in vivo setting. We performed the thermal simulation
on an anatomical phantom for 120 s to obtain the heating
pattern distribution within the phantom using our design.
The temperature distributions are shown in Figures 12
and 13. Figure 12 shows the normalized thermal distribution
in tissues with the laparoscopy-based and catheter-based
surgical instruments, where the edge of the red block is the
luminal surface and the edge of the blue block is the outer
surface of arterial wall. With the laparoscopy-based RDN
device, the temperature decreased to approximately 50% of
the peak temperature at the outer wall and to 30% of the
peak at the luminal surface (Figure 12(c)). With the catheter-
Figure 9. The temperature distribution in the prototype tip model. The model includes the surgical tip and gel. It was normalized with min-max scaling. The tem-
poral temperature profiles were extracted at the same position where the temperature was measured in the experiment marked with white dots (X1, X2, X3, Y1, Y2,
Y3, Z1, Z2, Z3).
Figure 8. Experimental validation protocol. Experiments were conducted with
the same protocol for setting 1 and setting 2, respectively.
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based RDN device, the temperatures at outer surface and
luminal surface of arterial wall were up to 95% and 85% of
the peak temperature, respectively, despite the cooling effect
of the blood flow as shown in Figure 12(d). When the tem-
perature of the cell increases above 45 C–50 C, protein
breakdown occurs, resulting in cell necrosis [29]. Based on
the simulation results obtained with the assumption that the
peak temperature generated at the electrode was 60 C, we
found that for the laparoscopy-based device the temperature
increased to 48 C–58 C at the sympathetic nerves, to 41.6 C
at the outer wall of the artery and to 39.3 C at the inner
wall of the artery. For the catheter-based device, under simi-
lar conditions, the temperature increased to 46 C–54 C at
the renal sympathetic nerve, to 58.9 C at the outer wall of
the artery, and to 56.6 C at the inner wall of the artery. We
found that the both laparoscopic and catheter-based RDN
may result in necrosis at the nerve since the temperature rise
for both cases are more than 45 C. However, the results sug-
gests that the laparoscopy-based system is safer since the
temperature at the inner wall is lower than 45 C, while the
catheter-based system could cause serious damage to inner
walls, which results in serious side effects such as stenosis,
since the temperature rise is more than 45 C.
Thus, our simulation results clearly show that the laparos-
copy-based approach would be safer while effectively elimi-
nating the renal sympathetic nerves. Figure 13 shows the
temperature distribution as a function of blood perfusion
rate for perfusion rates of 10,000, 5000, and 0ml/min/kg. As
shown in the graph, the temperature inside the artery
decreased as the blood perfusion rate increased, resulting in
the blood cooling effect. Thus, the lumen inside the artery
receives drastically reduced heat from the bipolar electrode
located outside the artery.
In the real laparoscopic surgery, the fat surrounding the
renal artery are removed, the artery is exposed to allow the
wrapping of the renal artery by the surgical tip, and renal
vein locates very close to the artery. We modelled the renal
Figure 10. The temporal temperature at the nine measurement positions: (a–c) setting 1 (r¼ 0.23 S/m, e¼ 43), (d–f) setting 2 (r¼ 0.35 S/m, e¼ 72). The solid
lines represent the simulation results, while the dot lines represent the experiment results. Each graph was normalized by the difference between the initial and
average temperatures during the last 60 s of the power-on period.
Table 2. Comparison of experimental and 3-D simulation normalized tempera-
ture profiles.
Setting Axis Method s [sec] SD E [%] Max E [%]
1
r¼ 0.23 S/m, x Exp. 83 0.0320 2.8 13.9
e¼ 43 Simul. 81
y Exp. 110 0.0285 2.9 9.9
Simul. 116
z Exp. 171 0.0329 1.7 6.4
Simul. 137
2
r¼ 0.65 S/m, x Exp. 76 0.0348 3.3 10.3
e¼ 72 Simul. 69
y Exp. 99 0.0222 3.7 13.1
Simul. 112
z Exp. 150 0.0368 1.7 5.0
Simul. 132
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vein, which is located posterior to the surgical tip, to exam-
ine the effects of heat radiation to the surrounding anatomy.
Figure 14 plots the temperature at the renal vein with and
without the insertion of metal strip that is posterior to the
instrument. The normalized graph demonstrates that the
temperature at the vein was slightly elevated without the
metal strip while using our device, and thus, safety can be
enhanced by reducing the heat radiated to the rear side of
the instrument.
Discussion
In this study, we showed proof of concept of a newly
designed laparoscopy-based RDN system through simula-
tion study and validation experiments. The high level of
agreement between measured and simulated thermal
results confirm our findings. Simulation results confirmed
that the laparoscopy-based system can address the limita-
tions of the catheter-based system in treating hypertension.
The results of numerical simulations showed that heat dis-
tributions induced by the electric fields are always greater
in regions closer to the electrodes. In addition, blood
perfusion inside the arteries causes a cooling effect result-
ing in significantly reduced harmful effects compared to
the catheter-based approach. Thus, the laparoscopy-based
RDN approach, which includes placing the electrodes dir-
ectly on the nerve outside the artery, can remove the
renal nerves more safely and effectively than the catheter-
based RDN approach, which includes positioning the elec-
trodes inside the artery. The laparoscopic RDN system has
other advantages due to access from the outside of the
artery. First, by wrapping the renal arteries completely by
a surgical tip, the renal nerves can be completely removed
regardless of the distance. Second, by inserting the therm-
ometer into the surgical instruments, the temperature rise
in the nerves positioned outside the arteries can be moni-
tored during the procedure allowing stable control and
ensuring safety and efficacy.
The main limitation of our study, however, is that we
established the feasibility of our design mainly via simulation
and in vitro studies. In the real-world environment, the
behavior of the system could be very different from these
simulation results. Thus, as a next step of verification that is
closer to the real-world environment, we plan to conduct our
Figure 11. (a–b) Heat pattern matching (Y-component) when all the simulation results were obtained at the center of the temperature probe hole. (c–d) Heat pat-
tern matching (Y-component) when the simulation results obtained with best position optimization in the hole. Each graph was normalized by the difference
between the initial and average temperatures during the last 60 s of the power-on period.
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study on an animal surgical model as well as ex vivo model
along with histological examination to confirm RDN effective-
ness and safety of surrounding tissue.
This laparoscopy-based method can change the paradigm
of hypertension treatment, and it can also be extended for
treating many other diseases caused by abnormalities of the
central nervous system, such as sleep apnea, depression and
heart diseases. In addition, secondary complications could be
prevented through improved primary treatment [1,2,30–33].
When our laparoscopic surgical instrument is developed, it
could be applied to the robotic surgical system to establish
less invasive and more accurate RDN method. Thus, the
development of this novel laparoscopy-based RDN procedure
can be significantly beneficial for a wide variety of patient
populations.
Conclusions
In this study, we proposed a novel laparoscopy-based elec-
trosurgical RDN device for resistant hypertension treatment.
The thermal distributions induced by this new surgical instru-
ment was evaluated and compared with catheter-based RDN
system using simulation method. The simulation results
Figure 12. Cross-sectional views of the heat distribution: (a) laparoscopy-based
RDN, (b) catheter-based RDN. Two-dimensional temperature profiles: (c) laparos-
copy-based RDN, (d) catheter-based RDN (red block: renal arterial lumen, blue
blocks: renal arterial wall, black line: position of the electrode). Each graph was
normalized with min-max scaling, respectively.
Figure 13. Two-dimensional temperature profiles according to the blood perfu-
sion rate (red block: renal arterial lumen, blue blocks: arterial wall). The graph
was normalized with min-max scaling.
Figure 14. Blocking thermal radiation to the renal vein using Nitinol (con-
ductor): (a) without metal strip and (b) with metal strip. (c) Two-dimensional
temperature profiles with or without metal strip (red block: renal arterial lumen,
blue block: renal arterial wall, gray block: renal vein). Each data were normalized
with minmax scaling, respectively.
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showed that our device is safer and more effective than the
existing catheter-based systems. Our approach, is effective in
blocking the sympathetic nerves located even beyond 2mm
from the luminal surface, which are otherwise left untreated
by previous catheter-based RDN system. Our in vitro experi-
mental results validated the simulation results. Going for-
ward, we will conduct our study on an animal surgical model
along with histological examination to confirm RDN effective-
ness and safety of surrounding tissue. The success of this sys-
tem will ultimately provide a safe and effective treatment for
resistant hypertension and may also contribute toward the
treatment of refractory heart disease, and arterial fibrillation.
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